Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 236Lymphoma 176Lymphoma, Large B-Cell, Diffuse 171Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Lymphoma, Follicular 77Lymphoma, Non-Hodgkin 72Burkitt Lymphoma 66Multiple Myeloma 62Leukemia 57Hodgkin Disease 45Lymphoma, Mantle-Cell 41Neoplasms 34Lymphoma, T-Cell, Peripheral 31Lymphoma, B-Cell 30Lymphoma, B-Cell, Marginal Zone 27Lymphoma, Large-Cell, Anaplastic 26Lymphoma, Large-Cell, Immunoblastic 24Neoplasm Metastasis 23Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Neoplasms, Plasma Cell 21Recurrence 19Immunoblastic Lymphadenopathy 15Dendritic Cell Sarcoma, Interdigitating 15Lymphoma, T-Cell 14Leukemia, Biphenotypic, Acute 10Waldenstrom Macroglobulinemia 9Blast Crisis 9Primary Myelofibrosis 8Myelodysplastic Syndromes 8

Interventions

Metformin 2Leuprolide 2Collagenases 2Clomiphene 2tremelimumab 1durvalumab 1Temozolomide 1Streptozocin 1Spironolactone 1Specimen Handling 1Radiosurgery 1Radiation 1Propofol 1Prednisone 1Plasma Exchange 1Nivolumab 1Midazolam 1Mercaptopurine 1Melphalan 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1Infliximab 1Immunoglobulins 1High-Throughput Nucleotide Sequencing 1Fentanyl 1FANG vaccine 1Cyclophosphamide 1Clomipramine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rare Diseases × Prednisone × Clear all
NCT00004436 2015-03-25

Randomized Study of Hormonal Regulation of Infantile Hemangioma

FDA Office of Orphan Products Development

Phase NA Completed
30 enrolled

Hemangioma, Respiratory Tract Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡